Oppenheimer Comments on Centene Corporation’s Q4 2019 Earnings (CNC)
Centene Corporation (NYSE:CNC) – Equities research analysts at Oppenheimer issued their Q4 2019 earnings per share estimates for Centene in a research note issued on Tuesday. Oppenheimer analyst M. Wiederhorn forecasts that the company will post earnings of $1.53 per share for the quarter. Oppenheimer currently has a “Outperform” rating and a $122.00 price objective on the stock.
Centene (NYSE:CNC) last issued its quarterly earnings data on Tuesday, October 24th. The company reported $1.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.11. The firm had revenue of $11.90 billion during the quarter, compared to analysts’ expectations of $11.75 billion. Centene had a return on equity of 14.79% and a net margin of 1.81%. Centene’s revenue was up 9.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.12 earnings per share.
Centene (CNC) traded down $0.35 during trading on Thursday, reaching $111.00. The company’s stock had a trading volume of 1,078,375 shares, compared to its average volume of 1,400,000. The company has a quick ratio of 0.99, a current ratio of 0.99 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $19,150.00, a P/E ratio of 22.93, a price-to-earnings-growth ratio of 1.35 and a beta of 0.70. Centene has a one year low of $61.37 and a one year high of $111.76.
In other news, EVP Keith H. Williamson sold 5,000 shares of Centene stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $100.11, for a total value of $500,550.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Robert K. Ditmore sold 4,167 shares of Centene stock in a transaction on Thursday, October 26th. The shares were sold at an average price of $90.42, for a total value of $376,780.14. The disclosure for this sale can be found here. In the last ninety days, insiders sold 27,917 shares of company stock valued at $2,777,255. Company insiders own 3.00% of the company’s stock.
Several large investors have recently made changes to their positions in the company. MML Investors Services LLC grew its position in shares of Centene by 1.0% in the second quarter. MML Investors Services LLC now owns 3,587 shares of the company’s stock valued at $287,000 after purchasing an additional 34 shares during the period. Gyroscope Capital Management Group LLC boosted its holdings in Centene by 4.7% in the second quarter. Gyroscope Capital Management Group LLC now owns 2,942 shares of the company’s stock valued at $235,000 after acquiring an additional 132 shares during the last quarter. Nordea Investment Management AB boosted its holdings in Centene by 2.3% in the second quarter. Nordea Investment Management AB now owns 9,663 shares of the company’s stock valued at $772,000 after acquiring an additional 216 shares during the last quarter. Profund Advisors LLC boosted its holdings in Centene by 3.6% in the second quarter. Profund Advisors LLC now owns 7,129 shares of the company’s stock valued at $569,000 after acquiring an additional 246 shares during the last quarter. Finally, Elk Creek Partners LLC boosted its holdings in Centene by 11.5% in the third quarter. Elk Creek Partners LLC now owns 5,264 shares of the company’s stock valued at $509,000 after acquiring an additional 542 shares during the last quarter. 92.16% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This piece was first posted by American Banking News and is the property of of American Banking News. If you are accessing this piece on another website, it was copied illegally and reposted in violation of international trademark and copyright laws. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/18/oppenheimer-comments-on-centene-corporations-q4-2019-earnings-cnc.html.
Centene Company Profile
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.